Publication Name	World Journal of Gastroenterology
Manuscript ID	6348
Country	Germany

Received	2013-10-14 10:46
Peer-Review Started	2013-10-14 12:48
To Make the First Decision	2013-12-03 19:00
Return for Revision	2013-12-05 10:14
Revised	2013-12-31 04:22
Second Decision	2014-02-27 11:16
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-02-27 11:34
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-04-24 12:34
Publish the Manuscript Online	2014-05-14 10:58

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Surgery
Manuscript Type	Topic Highlights
Article Title	Liver transplantation for malignancy: Current treatment strategies and future perspectives
Manuscript Source	Invited Manuscript
All Author List	Christina Hackl, Hans J Schlitt, Gabriele I Kirchner, Birgit Knoppke and Martin Loss
Funding Agency and Grant Number
Corresponding Author	Martin Loss, MD, Department of Surgery, University Hospital Regensburg, Franz Josef Strauss Allee 11, 93053 Regensburg, Germany. Martin.Loss@ukr.de
Key Words	Hepatocellular; Fibrolamellar; Carcinoma; Cholangiocellular; Hepatoblastoma; Liver metastases
Core Tip	Liver transplantation for malignancy is a medical and ethical challenge with regard to oncologic outcome and allocation justice. Childhood hepatoblastoma, epithelioid hemangioendothelioma, limited hepatocellular carcinoma and fibrolamellar carcinoma are proven indications for liver transplantation. Recent clinical trials have suggested cholangiocellular adenocarcinoma and hepatic metastases originating from neuroendocrine tumors as new indications in selected patients. Ongoing research may further widen indications for liver transplantation in malignant disease and therefore also complicate organ allocation. Living-donor liver transplantation may offer a solution for selected patients.
Publish Date	2014-05-14 10:58
Citation	Hackl C, Schlitt HJ, Kirchner GI, Knoppke B, Loss M. Liver transplantation for malignancy: Current treatment strategies and future perspectives. World J Gastroenterol 2014; 20(18): 5331-5344
URL	http://www.wjgnet.com/1007-9327/full/v20/i18/5331.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i18.5331

Full Article (PDF)	WJG-20-5331.pdf
Full Article (Word)	WJG-20-5331.doc
Manuscript File	6348-Review.doc
Answering Reviewers	6348-Answering reviewers.pdf
Copyright License Agreement	6348-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	6348-Language certificate.pdf
Peer-review Report	6348-Peer review(s).pdf
Scientific Editor Work List	6348-Scientific editor work list.doc